Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C
- PMID: 16950201
- DOI: 10.1016/j.bbrc.2006.08.114
Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C
Abstract
Anti-EGFR monoclonal antibodies LA22 and Erbitux bind to different epitopes of EGFR. The chemimmunoconjugates of MMC with LA22 or Erbitux were prepared, and in vitro cytotoxicity assays with A549 cells showed that LA22-MMC was much more potent than Erbitux or Erbitux-MMC. Viabilities of A549 cells treated with LA22-MMC, Erbitux or Erbitux-MMC were 35%, 94%, and 81%, respectively. Immunoscintigraphy of xenografts of human A431 and A549 cells in nude mice both showed that (125)I-labeled-LA22-MMC enriched in tumor sites prominently. Most importantly, in vivo assays showed LA22-MMC was significantly more effective than free drug MMC in the treatment of subcutaneous xenografts of human A431 cells in nude mice (83% inhibition for LA22-MMC and 30% for MMC). We concluded that LA22-MMC could be a very potent drug for treatment of solid tumors.
Similar articles
-
In-vitro internalization and in-vivo tumor uptake of anti-EGFR monoclonal antibody LA22 in A549 lung cancer cells and animal model.Cancer Biother Radiopharm. 2009 Feb;24(1):15-24. doi: 10.1089/cbr.2008.0537. Cancer Biother Radiopharm. 2009. PMID: 19216631
-
Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.J Natl Cancer Inst. 2005 Nov 16;97(22):1663-70. doi: 10.1093/jnci/dji373. J Natl Cancer Inst. 2005. PMID: 16288119
-
[Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].Zhongguo Yao Li Xue Bao. 1990 Nov;11(6):556-60. Zhongguo Yao Li Xue Bao. 1990. PMID: 2130622 Chinese.
-
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.Bioconjug Chem. 2003 Mar-Apr;14(2):302-10. doi: 10.1021/bc020033z. Bioconjug Chem. 2003. PMID: 12643740
-
[The selective cytotoxicity of monoclonal antibody conjugated with mitomycin C on human gastric cancer cells].Yao Xue Xue Bao. 1989;24(11):801-6. Yao Xue Xue Bao. 1989. PMID: 2618675 Chinese.
Cited by
-
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.Cancer Immunol Immunother. 2012 Oct;61(10):1617-26. doi: 10.1007/s00262-012-1219-3. Epub 2012 Feb 19. Cancer Immunol Immunother. 2012. PMID: 22350071 Free PMC article.
-
The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.J Oncol. 2011;2011:125467. doi: 10.1155/2011/125467. Epub 2011 Jun 13. J Oncol. 2011. PMID: 21772841 Free PMC article.
-
A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.J Immunol Res. 2019 Jan 13;2019:3017360. doi: 10.1155/2019/3017360. eCollection 2019. J Immunol Res. 2019. PMID: 30733972 Free PMC article.
-
Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib.Cancer Chemother Pharmacol. 2013 Aug;72(2):341-8. doi: 10.1007/s00280-013-2198-6. Epub 2013 Jun 8. Cancer Chemother Pharmacol. 2013. PMID: 23748900 Free PMC article.
-
Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models.Mol Imaging Biol. 2011 Feb;13(1):112-20. doi: 10.1007/s11307-010-0302-4. Mol Imaging Biol. 2011. PMID: 20383594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
